Stay updated on Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:58:06.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with a basic error screen and removing navigation to the study details.
    Difference
    19%
    Check dated 2026-09-20T20:08:25.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous revision label, indicating a newer version of the study page.
    Difference
    0.1%
    Check dated 2026-08-30T22:27:51.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, representing a minor metadata update to the page version rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-09T09:59:11.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision header updated from v3.6.3 to v3.6.4, indicating a minor update to the page version. The study details and visible content are unchanged.
    Difference
    0.1%
    Check dated 2026-07-25T17:55:38.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a minor deployment/build update for the page. This change does not affect study information or how it is presented to users.
    Difference
    0.1%
    Check dated 2026-07-04T08:22:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.